Global Menopause Treatment Market Growth (Status and Outlook) 2023-2029

Global Menopause Treatment Market Growth (Status and Outlook) 2023-2029

Menopause, also known as the climacteric, is the time in most women's lives when menstrual periods stop permanently, and they are no longer able to bear children. Menopause typically occurs between 49 and 52 years of age. Medical professionals often define menopause as having occurred when a woman has not had any vaginal bleeding for a year. It may also be defined by a decrease in hormone production by the ovaries. In those who have had surgery to remove their uterus but still have ovaries, menopause may be viewed to have occurred at the time of the surgery or when their hormone levels fell. Following the removal of the uterus, symptoms typically occur earlier, at an average of 45 years of age.

LPI (LP Information)' newest research report, the “Menopause Treatment Industry Forecast” looks at past sales and reviews total world Menopause Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Menopause Treatment sales for 2023 through 2029. With Menopause Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Menopause Treatment industry.

This Insight Report provides a comprehensive analysis of the global Menopause Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Menopause Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Menopause Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Menopause Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Menopause Treatment.

The global Menopause Treatment market size is projected to grow from US$ 2454.4 million in 2022 to US$ 2915.5 million in 2029; it is expected to grow at a CAGR of 2.5% from 2023 to 2029.

Menopause is a natural stage of life. It is not a disease or a disorder. Therefore, it does not automatically require any kind of medical treatment. However, in those cases where the physical, mental, and emotional effects of perimenopause are strong enough that they significantly disrupt the life of the woman experiencing them, palliative medical therapy may sometimes be appropriate.

This report presents a comprehensive overview, market shares, and growth opportunities of Menopause Treatment market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Hormonal Treatment
Non-Hormonal Treatment

Segmentation by application
Hospitals
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Novartis
Novo Nordisk
Pfizer
Allergan
Emcure Pharmaceuticals
Eli Lilly And Company
Cipla
Teva Pharmaceutical Industries

Please note: The report will take approximately 2 business days to prepare and deliver.